Dr. James G. Fujimoto of U.S. Awarded 45th Honda Prize for His Team's Development of Optical Coherence Tomography (OCT): Real-time Tissue Imaging Technology PressReach · Dec 9, 2024
New Data from PROMMIS Study Highlights the Power of SKY92 in Identifying High-Risk Multiple Myeloma Patients PressReach · Dec 8, 2024
Investigational Epcoritamab (DuoBody® CD3xCD20) Combination Therapy Shows High Response Rates in Clinical Trial of Patients With Relapsed or Refractory (R/R) Follicular Lymphoma (FL) PressReach · Dec 8, 2024
University of Nebraska Wins the Abbott and Big Ten Conference's Nationwide 'We Give Blood Drive' Competition, Receives $1 Million Grant from Abbott PressReach · Dec 8, 2024
Researchers Report New Opportunities to Improve Quality of Life for People with Non-Malignant Blood Disorders PressReach · Dec 8, 2024
Blueprint Medicines' Continued Leadership in Redefining the Standard of Care in Systemic Mastocytosis Highlighted at 2024 ASH Annual Meeting PressReach · Dec 8, 2024
Bamboo Technology's HereHear Virtual AI Therapist Joins Berkeley Skydeck IPP Program PressReach · Dec 7, 2024
Auditor General Report sheds light on Ford's reckless waste of public dollars: OPSEU/SEFPO PressReach · Dec 7, 2024
New Preclinical Data Demonstrate Potential of Capsida's IV Gene Therapy for STXBP1-DEE to Correct all Disease Manifestations PressReach · Dec 7, 2024
Jazz Pharmaceuticals to Showcase New Real-World Evidence Reinforcing Epidiolex® (cannabidiol) Benefits and Broad-Spectrum Efficacy in Treatment-Resistant Epilepsies at the American Epilepsy Society 2024 Annual Meeting PressReach · Dec 7, 2024
